Dr. Günalp Uzun (Tübingen/ DE), Dr. Karina Althaus (Tübingen/ DE), Franziska Lyshy (Tübingen/ DE), Prof. Dr. Tamam Bakchoul (Tübingen/ DE)
Background
Anti-platelet factor 4 (PF4) antibodies have been identified as the cause of vaccine-induced immune thrombotic thrombocytopenia following adenoviral vector-based COVID-19 vaccines. Previous studies have primarily focused on determining the frequency of anti-PF4 antibodies shortly after the first COVID-19 vaccination, leaving the rates of anti-PF4 antibody positivity after second vaccinations largely unknown.
Methods
In this study, we analyzed serum samples from healthcare workers who had received at least two vaccines, with the first vaccine being the AstraZeneca (AZ) vaccine. Anti-PF4/heparin IgG antibody levels were determined using a commercially available ELISA kit. An optical density (OD) greater than 0.5 was considered a positive result.
Results
A total of 444 study participants (356 (80%) females and 88 (20%) males) with a median age of 48 years (ranging from 21 to 67 years) were included in this study. Serum samples were collected a median of 158 days (range: 76 to 209 days) after the second vaccination. Of the samples analyzed, 27 (6%) were positive by ELISA with a median OD of 0.728 ranging from 0.5 to 2.8. Specifically, there were 5 of 93 cases (5.3%) in individuals who received two AZ vaccinations, 15 of 226 cases (6.6%) in individuals who received AZ-Biontech/Pfizer vaccinations, and 7 of 125 cases (5.6%) in individuals who received AZ-Moderna vaccinations. Investigations into the platelet activation properties of these antibodies are ongoing.
Conclusion
The observed frequency of positive cases is consistent with findings from previous studies conducted after the first vaccination. However, the presence of cases with high OD values and the time elapsed since the second vaccination suggest the need for further studies to fully evaluate the clinical significance of vaccine-induced anti-PF4 antibodies.
Offenlegung Interessenkonflikt:
keine
Auf unserem Internetauftritt verwenden wir Cookies. Bei Cookies handelt es sich um kleine (Text-)Dateien, die auf Ihrem Endgerät (z.B. Smartphone, Notebook, Tablet, PC) angelegt und gespeichert werden. Einige dieser Cookies sind technisch notwendig um die Webseite zu betreiben, andere Cookies dienen dazu die Funktionalität der Webseite zu erweitern oder zu Marketingzwecken. Abgesehen von den technisch notwendigen Cookies, steht es Ihnen frei Cookies beim Besuch unserer Webseite zuzulassen oder nicht.